Citations (131)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Wubetu Yihunie, Getinet Nibret & Yibeltal Aschale. (2023) Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review. Clinical Pharmacology: Advances and Applications 15, pages 77-98.
Read now
Read now
Qian Wang, Ziyang Song, Jinghuan Yang, Qian He, Qunying Mao, Yu Bai, Jianyang Liu, Chaoqiang An, Xujia Yan, Bopei Cui, Lifang Song, Dong Liu, Miao Xu & Zhenglun Liang. (2022) Transcriptomic analysis of the innate immune signatures of a SARS-CoV-2 protein subunit vaccine ZF2001 and an mRNA vaccine RRV. Emerging Microbes & Infections 11:1, pages 1145-1153.
Read now
Read now
Nusrat Zahan Rouf, Sumit Biswas, Nawseen Tarannum, Labiba Mustabina Oishee & Mutia Masuka Muna. (2022) Demystifying mRNA vaccines: an emerging platform at the forefront of cryptic diseases. RNA Biology 19:1, pages 386-410.
Read now
Read now
Evalyne M Jansen, Henderik W Frijlink, Wouter LJ Hinrichs & Mitchel JR Ruigrok. (2022) Are inhaled mRNA vaccines safe and effective? A review of preclinical studies. Expert Opinion on Drug Delivery 19:11, pages 1471-1485.
Read now
Read now
Carolina Lopes, Joana Cristóvão, Vânia Silvério, Paulo Roque Lino & Pedro Fonte. (2022) Microfluidic production of mRNA-loaded lipid nanoparticles for vaccine applications. Expert Opinion on Drug Delivery 19:10, pages 1381-1395.
Read now
Read now
Velasco Cimica, Jose M Galarza, Sujatha Rashid & Timothy T. Stedman. (2021) Current development of Zika virus vaccines with special emphasis on virus-like particle technology. Expert Review of Vaccines 20:11, pages 1483-1498.
Read now
Read now
Khalid Hajissa & Ali Mussa. (2021) Positive aspects of the mRNA platform for SARS-CoV-2 vaccines. Human Vaccines & Immunotherapeutics 17:8, pages 2445-2447.
Read now
Read now
Rosana Simón-Vázquez, Mercedes Peleteiro & África González-Fernández. (2020) Polymeric nanostructure vaccines: applications and challenges. Expert Opinion on Drug Delivery 17:7, pages 1007-1023.
Read now
Read now
Articles from other publishers (123)
Kimberly J. Hassett, Ivana Liric Rajlic, Kapil Bahl, Rebecca White, Kristen Cowens, Eric Jacquinet & Kristine E. Burke. (2024) mRNA vaccine trafficking and resulting protein expression after intramuscular administration. Molecular Therapy - Nucleic Acids 35:1, pages 102083.
Crossref
Crossref
Camille Malburet, Aurelien Carboni, Stephanie Guinamand, Hemantkumar Naik & Stephanie Fertier-Prizzon. (2024) mRNA extraction from lipid nanoparticles. Journal of Chromatography A 1714, pages 464545.
Crossref
Crossref
Feng Lin, Emma Z. Lin, Misa Anekoji, Thomas E. Ichim, Joyce Hu, Francesco M. Marincola, Lawrence D. Jones, Santosh Kesari & Shashaanka Ashili. (2023) Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines. Journal of Translational Medicine 21:1.
Crossref
Crossref
Jiayu Gu, Zhourui Xu, Qiqi Liu, Shiqi Tang, Wenguang Zhang, Shouxia Xie, Xiaoyan Chen, Jiajie Chen, Ken‐Tye Yong, Chengbin Yang & Gaixia Xu. (2023) Building a Better Silver Bullet: Current Status and Perspectives of Non‐Viral Vectors for mRNA Vaccines. Advanced Healthcare Materials.
Crossref
Crossref
Bevin Neill, Adriana Retamales Romero & Owen S. Fenton. (2023) Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy. ACS Applied Bio Materials.
Crossref
Crossref
Falak Goyal, Anandini Chattopadhyay, Umashanker Navik, Aklank Jain, P. Hemachandra Reddy, Gurjit Kaur Bhatti & Jasvinder Singh Bhatti. (2023) Advancing Cancer Immunotherapy: The Potential of mRNA Vaccines As a Promising Therapeutic Approach. Advanced Therapeutics.
Crossref
Crossref
Tian Tan, Shu-Ting Deng, Bing-Huo Wu, Qi Yang, Meng-Wan Wu, Hong Wu, Chen-Hui Cao & Chuan Xu. (2023) mRNA Vaccine - A New Cancer Treatment Strategy. Current Cancer Drug Targets 23:9, pages 669-681.
Crossref
Crossref
Cristiana Perrotta, Claudio Fenizia, Carla Carnovale, Marco Pozzi, Daria Trabattoni, Davide Cervia & Emilio Clementi. (2023) Updated Considerations for the Immunopharmacological Aspects of the “Talented mRNA Vaccines”. Vaccines 11:9, pages 1481.
Crossref
Crossref
Xue Feng, Zhiguo Su, Yuan Cheng, Guanghui Ma & Songping Zhang. (2023) Messenger RNA chromatographic purification: advances and challenges. Journal of Chromatography A 1707, pages 464321.
Crossref
Crossref
Nojoud Al Fayez, Majed S. Nassar, Abdullah A. Alshehri, Meshal K. Alnefaie, Fahad A. Almughem, Bayan Y. Alshehri, Abdullah O. Alawad & Essam A. Tawfik. (2023) Recent Advancement in mRNA Vaccine Development and Applications. Pharmaceutics 15:7, pages 1972.
Crossref
Crossref
Thao A Khuc, Gregery Pequeno, Monica Betancourt-Garcia, Adrienne M Casciato, Marissa Gomez-Martinez, Carlos D Arroyo, Bill D Pope, Shravan Narmala & Sohail Rao. (2023) The Effect of Third Dose of Pfizer/BioNTech and Moderna COVID-19 mRNA Vaccines on IgG Antibody Titers. Cureus.
Crossref
Crossref
Xiaolin Xu, Wencai Guan, Xiaolei Yu, Guoxiong Xu & Chenglong Wang. (2023) Non-interfacial self-assembly of synthetic protocells. Biomaterials Research 27:1.
Crossref
Crossref
Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao & Shubiao Zhang. (2023) Development and applications of mRNA treatment based on lipid nanoparticles. Biotechnology Advances 65, pages 108130.
Crossref
Crossref
Albert J. Czaja. (2023) Incorporating the Molecular Mimicry of Environmental Antigens into the Causality of Autoimmune Hepatitis. Digestive Diseases and Sciences 68:7, pages 2824-2842.
Crossref
Crossref
Nicholas J. Tursi, Ziyang Xu, Daniel W. Kulp & David B. Weiner. (2023) Gene‐encoded nanoparticle vaccine platforms for in vivo assembly of multimeric antigen to promote adaptive immunity. WIREs Nanomedicine and Nanobiotechnology 15:4.
Crossref
Crossref
Cees J. M. van Rijn, Killian E. Vlaming, Reinout A. Bem, Rob J. Dekker, Albert Poortinga, Timo Breit, Selina van Leeuwen, Wim A. Ensink, Kelly van Wijnbergen, John L. van Hamme, Daniel Bonn & Teunis B. H. Geijtenbeek. (2023) Low energy nebulization preserves integrity of SARS-CoV-2 mRNA vaccines for respiratory delivery. Scientific Reports 13:1.
Crossref
Crossref
Jordi Reina. (2023) The new generation of messenger RNA (mRNA) vaccines against influenza. Enfermedades infecciosas y microbiologia clinica (English ed.) 41:5, pages 301-304.
Crossref
Crossref
Jordi Reina. (2023) La nueva generación de vacunas de ARN mensajero (ARNm) frente a la gripe. Enfermedades Infecciosas y Microbiología Clínica 41:5, pages 301-304.
Crossref
Crossref
De‐feng Li, Qi‐song Liu, Mei‐feng Yang, Hao‐ming Xu, Min‐zheng Zhu, Yuan Zhang, Jing Xu, Cheng‐mei Tian, Jun Yao, Li‐sheng Wang & Yu‐jie Liang. (2023)
Nanomaterials for
mRNA
‐based therapeutics: Challenges and opportunities
. Bioengineering & Translational Medicine 8:3.
Crossref
Crossref
Halie M. Rando, Ronan Lordan, Likhitha Kolla, Elizabeth Sell, Alexandra J. Lee, Nils Wellhausen, Amruta Naik, Jeremy P. Kamil, Anthony Gitter, Casey S. Greene, John P. Barton, Simina M. Boca, Joel D. Boerckel, Christian Brueffer, James Brian Byrd, Stephen Capone, Shikta Capone, Anna Ada Dattoli, John J. Dziak, Jeffrey M. Field, Soumita Ghosh, Anthony Gitter, Rishi Raj Goel, Casey S. Greene, Marouen Ben Guebila, Daniel S. Himmelstein, Fengling Hu, Nafisa M. Jadavji, Jeremy P. Kamil, Sergey Knyazev, Likhitha Kolla, Alexandra J. Lee, Ronan Lordan, Tiago Lubiana, Temitayo Lukan, Adam L. MacLean, David Mai, Serghei Mangul, David Manheim, Lucy D’Agostino McGowan, Jesse G. Meyer, Ariel I. Mundo, Amruta Naik, YoSon Park, Dimitri Perrin, Yanjun Qi, Diane N. Rafizadeh, Bharath Ramsundar, Halie M. Rando, Sandipan Ray, Michael P. Robson, Vincent Rubinetti, Elizabeth Sell, Lamonica Shinholster, Ashwin N. Skelly, Yuchen Sun, Yusha Sun, Gregory L. Szeto, Ryan Velazquez, Jinhui Wang & Nils Wellhausen. (2023) The Coming of Age of Nucleic Acid Vaccines during COVID-19. mSystems 8:2.
Crossref
Crossref
Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, Ali Kamedi, Andrew O’ Neill, Ronan MacLoughlin & Mohammad Doroudian. (2023) Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections. Pharmaceutics 15:4, pages 1127.
Crossref
Crossref
Bingan Wu, Zhongtian Qi & Xijing Qian. (2023) Recent Advancements in Mosquito-Borne Flavivirus Vaccine Development. Viruses 15:4, pages 813.
Crossref
Crossref
Jingjing Liu, Xishan Lu, Xingxing Li, Weijin Huang, Enyue Fang, Wenjuan Li, Xiaohui Liu, Minglei Liu, Jia Li, Ming Li, Zelun Zhang, Haifeng Song, Bo Ying & Yuhua Li. (2023) Construction and immunogenicity of an mRNA vaccine against chikungunya virus. Frontiers in Immunology 14.
Crossref
Crossref
Dimitrios Bafaloukos, Ioanna Gazouli, Christos Koutserimpas & George Samonis. (2023) Evolution and Progress of mRNA Vaccines in the Treatment of Melanoma: Future Prospects. Vaccines 11:3, pages 636.
Crossref
Crossref
Doris Lambracht-Washington, Min Fu, Mary Wight-Carter, Matthew Riegel, Linda S. Hynan & Roger N. Rosenberg. (2023) DNA Aβ42 immunization via needle-less Jet injection in mice and rabbits as potential immunotherapy for Alzheimer's disease. Journal of the Neurological Sciences 446, pages 120564.
Crossref
Crossref
Sunny Kumar, Malini Basu, Pratyasha Ghosh, Aafreen Ansari & Mrinal K. Ghosh. (2022) COVID‐19: Clinical status of vaccine development to date. British Journal of Clinical Pharmacology 89:1, pages 114-149.
Crossref
Crossref
Hiroshi Nakayama, Yuko Nobe, Masami Koike & Masato Taoka. (2022) Liquid Chromatography–Mass Spectrometry-Based Qualitative Profiling of mRNA Therapeutic Reagents Using Stable Isotope-Labeled Standards Followed by the Automatic Quantitation Software Ariadne. Analytical Chemistry.
Crossref
Crossref
Shyh Poh Teo. (2021) Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273. Journal of Pharmacy Practice 35:6, pages 947-951.
Crossref
Crossref
Diana O. Lopez-Cantu, Xichi Wang, Hector Carrasco-Magallanes, Samson Afewerki, Xingcai Zhang, Joseph V. Bonventre & Guillermo U. Ruiz-Esparza. (2022) From Bench to the Clinic: The Path to Translation of Nanotechnology-Enabled mRNA SARS-CoV-2 Vaccines. Nano-Micro Letters 14:1.
Crossref
Crossref
Ingrid Andrêssa de Moura, Anna Jéssica Duarte Silva, Larissa Silva de Macêdo, Maria da Conceição Viana Invenção, Mylenna Máyra Gois de Sousa & Antonio Carlos de Freitas. (2022) Enhancing the Effect of Nucleic Acid Vaccines in the Treatment of HPV-Related Cancers: An Overview of Delivery Systems. Pathogens 11:12, pages 1444.
Crossref
Crossref
Mahtab Ghasemi Toudeshkchouei, Atefeh Tavakoli, Hossein Mohammadghasemi, Anita Karimi, Jafar Ai, Mohammad Rabiee & Navid Rabiee. (2022) Recent approaches to mRNA vaccine delivery by lipid-based vectors prepared by continuous-flow microfluidic devices. Future Medicinal Chemistry 14:21, pages 1561-1581.
Crossref
Crossref
Alessio Alesci, Marco Gitto, Magdalena Kotańska, Patrizia Lo Cascio, Anthea Miller, Noemi Nicosia, Angelo Fumia & Simona Pergolizzi. (2022) Immunogenicity, effectiveness, safety and psychological impact of COVID-19 mRNA vaccines. Human Immunology 83:11, pages 755-767.
Crossref
Crossref
Wanting Zhang, Yuxin Jiang, Yonglong He, Hamza Boucetta, Jun Wu, Zhongjian Chen & Wei He. (2022) Lipid carriers for mRNA delivery. Acta Pharmaceutica Sinica B.
Crossref
Crossref
Yen-Pin Lin, Yi-Shan Hsieh, Mei-Hsiu Cheng, Ching-Fen Shen, Ching-Ju Shen & Chao-Min Cheng. (2022) Using MicroRNA Arrays as a Tool to Evaluate COVID-19 Vaccine Efficacy. Vaccines 10:10, pages 1681.
Crossref
Crossref
Yangzhuo Gu, Jiangyao Duan, Na Yang, Yuxin Yang & Xing Zhao. (2022) mRNA vaccines in the prevention and treatment of diseases. MedComm 3:3.
Crossref
Crossref
Sazzad Shahrear & Abul Bashar Mir Md. Khademul Islam. (2022) Modeling of MT. P495, an mRNA-based vaccine against the phosphate-binding protein PstS1 of Mycobacterium tuberculosis. Molecular Diversity.
Crossref
Crossref
Ketaki ShindeSonam BendreNiraj KaleSuhit Gilda. (2022) The mRNA Vaccine Heralds a New Era in Vaccinology. Asian Journal of Pharmacy and Technology, pages 257-265.
Crossref
Crossref
Yuhan Tu, Zhiang Yao, Wenjing Yang, Shanhui Tao, Bin Li, Yun Wang, Zhijian Su & Shijun Li. (2022) Application of Nanoparticles in Tumour Targeted Drug Delivery and Vaccine. Frontiers in Nanotechnology 4.
Crossref
Crossref
Qing He, Hua Gao, Dejiang Tan, Heng Zhang & Jun-zhi Wang. (2022) mRNA cancer vaccines: Advances, trends and challenges. Acta Pharmaceutica Sinica B 12:7, pages 2969-2989.
Crossref
Crossref
Jinjin ChenJianzhu ChenQiaobing Xu. (2022) Current Developments and Challenges of mRNA Vaccines. Annual Review of Biomedical Engineering 24:1, pages 85-109.
Crossref
Crossref
Lukas Kofler & Stephan Forchhammer. (2022) Verzögerte Lokalreaktion mit subkutaner Infiltration nach Impfung mit mRNA-1273 – ein bisher unbeschriebenes Reaktionsmuster eines COVID-ArmsDelayed local reaction with subcutaneous infiltration after vaccination with mRNA-1273—a previously undescribed reaction pattern of COVID arm. Der Hautarzt 73:6, pages 488-490.
Crossref
Crossref
Surojit Banerjee, Debadri Banerjee, Anupama Singh & Vikas Anand Saharan. (2022) A Comprehensive Investigation Regarding the Differentiation of the Procurable COVID-19 Vaccines. AAPS PharmSciTech 23:4.
Crossref
Crossref
Abid Hussain, Haiyin Yang, Mengjie Zhang, Qing Liu, Ghallab Alotaibi, Muhammad Irfan, Huining He, Jin Chang, Xing-Jie Liang, Yuhua Weng & Yuanyu Huang. (2022) mRNA vaccines for COVID-19 and diverse diseases. Journal of Controlled Release 345, pages 314-333.
Crossref
Crossref
Kamil BATUR & Hakan YARDIMCI. (2022) mRNA AŞILARINDA GÜNCEL YAKLAŞIMLARCURRENT APPROACHES to mRNA VACCINES. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni 13:1, pages 1-10.
Crossref
Crossref
Andrei A. Deviatkin, Ruslan A. Simonov, Kseniya A. Trutneva, Anna A. Maznina, Elena M. Khavina & Pavel Y. Volchkov. (2022) Universal Flu mRNA Vaccine: Promises, Prospects, and Problems. Vaccines 10:5, pages 709.
Crossref
Crossref
Fatemeh Nafian, Simin Nafian, Ghazal Soleymani, Zahra Pourmanouchehri, Mahnaz Kiyanjam, Sharareh Berenji Jalaei, Hanie Jeyroudi & Sayed Mohammad Mohammdi. 2022. Vaccine Development. Vaccine Development.
Enyue Fang, Xiaohui Liu, Miao Li, Zelun Zhang, Lifang Song, Baiyu Zhu, Xiaohong Wu, Jingjing Liu, Danhua Zhao & Yuhua Li. (2022) Advances in COVID-19 mRNA vaccine development. Signal Transduction and Targeted Therapy 7:1.
Crossref
Crossref
Olanrewaju Ayodeji Durojaye, Divine Mensah Sedzro, Mukhtar Oluwaseun Idris, Abeeb Abiodun Yekeen, Adeola Abraham Fadahunsi & Oluwaseun Suleiman Alakanse. (2022) Identification of a Potential mRNA‐based Vaccine Candidate against the SARS‐CoV‐2 Spike Glycoprotein: A Reverse Vaccinology Approach. ChemistrySelect 7:7.
Crossref
Crossref
Alysia Cox, Siyoung A. Lim & Eun Ji Chung. (2022) Strategies to deliver RNA by nanoparticles for therapeutic potential. Molecular Aspects of Medicine 83, pages 100991.
Crossref
Crossref
Giulia Anderluzzi, Gustavo Lou, Stuart Woods, Signe Tandrup Schmidt, Simona Gallorini, Michela Brazzoli, Russell Johnson, Craig W. Roberts, Derek T. O'Hagan, Barbara C. Baudner & Yvonne Perrie. (2022) The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency. Journal of Controlled Release 342, pages 388-399.
Crossref
Crossref
Jie Tang, Larry Cai, Chuanfei Xu, Si Sun, Yuheng Liu, Joseph Rosenecker & Shan Guan. (2022) Nanotechnologies in Delivery of DNA and mRNA Vaccines to the Nasal and Pulmonary Mucosa. Nanomaterials 12:2, pages 226.
Crossref
Crossref
Karnyart Samnuan, Anna K Blakney, Paul F McKay & Robin J Shattock. (2022) Design-of-experiments in vitro transcription yield optimization of self-amplifying RNA. F1000Research 11, pages 333.
Crossref
Crossref
Dixita Ishani Viswanath, Hsuan-Chen Liu, David P. Huston, Corrine Ying Xuan Chua & Alessandro Grattoni. (2022) Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines. Biomaterials 280, pages 121297.
Crossref
Crossref
Frantisek Drafi, Silvester Ponist, Bruno Sepodes & Katarina Bauerova. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
321
341
.
Rushit N. Lodaya, Sonia Gregory, Mansoor M. Amiji & Derek T. O'Hagan. 2022. Practical Aspects of Vaccine Development. Practical Aspects of Vaccine Development
9
25
.
Abhijeet Nayak. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics
163
200
.
Melike Ongun, Abhijeet Girish Lokras, Camilla Foged & Aneesh Thakur. 2022. Messenger RNA Therapeutics. Messenger RNA Therapeutics
237
255
.
Girolamo Giannotta & Nicola Giannotta. (2021) mRNA COVID-19 Vaccines and Long-Lived Plasma Cells: A Complicated Relationship. Vaccines 9:12, pages 1503.
Crossref
Crossref
Aman Ishaqat & Andreas Herrmann. (2021) Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics. Journal of the American Chemical Society 143:49, pages 20529-20545.
Crossref
Crossref
Tobias Monschein, Tobias Zrzavy, Micha Löbermann, Alexander Winkelmann, Thomas Berger, Paulus Rommer, Hans-Peter Hartung & Uwe K. Zettl. (2021) Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: ImpfstofftechnologienThe corona pandemic and multiple sclerosis: vaccinations and their implications for patients—Part 2: vaccine technologies. Der Nervenarzt 92:12, pages 1283-1292.
Crossref
Crossref
Davide Ferrari, Alessandra Mangia, Maria Sestina Spanò, Lucia Zaffarano, Marco Viganò, Chiara Di Resta, Massimo Locatelli, Fabio Ciceri & Elena De Vecchi. (2021) Quantitative serological evaluation as a valuable tool in the COVID-19 vaccination campaign. Clinical Chemistry and Laboratory Medicine (CCLM) 59:12, pages 2019-2026.
Crossref
Crossref
Bruna Aparecida Souza Machado, Katharine Valéria Saraiva Hodel, Larissa Moraes dos Santos Fonseca, Luís Alberto Brêda Mascarenhas, Leone Peter Correia da Silva Andrade, Vinícius Pinto Costa Rocha, Milena Botelho Pereira Soares, Peter Berglund, Malcolm S. Duthie, Steven G. Reed & Roberto Badaró. (2021) The Importance of RNA-Based Vaccines in the Fight against COVID-19: An Overview. Vaccines 9:11, pages 1345.
Crossref
Crossref
Hannah S. Eisfeld, Alexander Simonis, Sandra Winter, Jason Chhen, Luisa J. Ströh, Thomas Krey, Manuel Koch, Sebastian J. Theobald & Jan Rybniker. (2021) Viral Glycoproteins Induce NLRP3 Inflammasome Activation and Pyroptosis in Macrophages. Viruses 13:10, pages 2076.
Crossref
Crossref
C. Galván-Casas, A. Català & C. Muñoz-Santos. (2021) SARS-CoV-2 Vaccines and the Skin. Actas Dermo-Sifiliográficas (English Edition) 112:9, pages 828-836.
Crossref
Crossref
C. Galván-Casas, A. Català & C. Muñoz-Santos. (2021) Vacunas frente a SARS-CoV-2 y piel. Actas Dermo-Sifiliográficas 112:9, pages 828-836.
Crossref
Crossref
Lars Wommer, Patrick Meiers, Isabelle Kockler, Roland Ulber & Percy Kampeis. (2021) Development of a 3D‐printed single‐use separation chamber for use in mRNA‐based vaccine production with magnetic microparticles. Engineering in Life Sciences 21:10, pages 573-588.
Crossref
Crossref
Lars Wommer, Winda Soerjawinata, Roland Ulber & Percy Kampeis. (2021) Agglomeration behaviour of magnetic microparticles during separation and recycling processes in mRNA purification. Engineering in Life Sciences 21:10, pages 558-572.
Crossref
Crossref
Maryam Bidram, Yue Zhao, Natalia G. Shebardina, Alexey V. Baldin, Alexandr V. Bazhin, Mohamad Reza Ganjalikhany, Andrey A. ZamyatninJr.Jr. & Mazdak Ganjalikhani-hakemi. (2021) mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients. Vaccines 9:10, pages 1060.
Crossref
Crossref
An-Katrien Minnaert, Helena Vanluchene, Rein Verbeke, Ine Lentacker, Stefaan C. De Smedt, Koen Raemdonck, Niek N. Sanders & Katrien Remaut. (2021) Strategies for controlling the innate immune activity of conventional and self-amplifying mRNA therapeutics: Getting the message across. Advanced Drug Delivery Reviews 176, pages 113900.
Crossref
Crossref
Nitika Thakur, Sudheesh K. Shukla & Chaudhery M. Hussain. 2021. Detection and Analysis of SARS Coronavirus. Detection and Analysis of SARS Coronavirus
57
73
.
Ger T. Rijkers, Nynke Weterings, Andres Obregon-Henao, Michaëla Lepolder, Taru S. Dutt, Frans J. van Overveld & Marcela Henao-Tamayo. (2021) Antigen Presentation of mRNA-Based and Virus-Vectored SARS-CoV-2 Vaccines. Vaccines 9:8, pages 848.
Crossref
Crossref
Davide Ferrari, Chiara Di Resta, Rossella Tomaiuolo, Eleonora Sabetta, Marina Pontillo, Andrea Motta & Massimo Locatelli. (2021) Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects. Vaccine 39:31, pages 4256-4260.
Crossref
Crossref
Paul Löffler. (2021) Review: Vaccine Myth-Buster – Cleaning Up With Prejudices and Dangerous Misinformation. Frontiers in Immunology 12.
Crossref
Crossref
Giuseppe Cappellano, Hugo Abreu, Chiara Casale, Umberto Dianzani & Annalisa Chiocchetti. (2021) Nano-Microparticle Platforms in Developing Next-Generation Vaccines. Vaccines 9:6, pages 606.
Crossref
Crossref
M. Lefebvre, N. Vignier, B. Pitard, E. Botelho-Nevers, B. Wyplosz, R. Cohen & O. Epaulard. (2021) COVID-19 vaccines: Frequently asked questions and updated answers. Infectious Diseases Now 51:4, pages 319-333.
Crossref
Crossref
André E. Nel & Jeff F. Miller. (2021) Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape. ACS Nano 15:4, pages 5793-5818.
Crossref
Crossref
Shani Witman Tsur, Eli Adrian Zaher, Meydan Tsur, Karolina Kania & Alicja Kalinowska-Łyszczarz. (2021) Current Immunological and Clinical Perspective on Vaccinations in Multiple Sclerosis Patients: Are They Safe after All?. International Journal of Molecular Sciences 22:8, pages 3859.
Crossref
Crossref
Jatin Machhi, Farah Shahjin, Srijanee Das, Milankumar Patel, Mai Mohamed Abdelmoaty, Jacob D. Cohen, Preet Amol Singh, Ashish Baldi, Neha Bajwa, Raj Kumar, Lalit K. Vora, Tapan A. Patel, Maxim D. Oleynikov, Dhruvkumar Soni, Pravin Yeapuri, Insiya Mukadam, Rajashree Chakraborty, Caroline G. Saksena, Jonathan Herskovitz, Mahmudul Hasan, David Oupicky, Suvarthi Das, Ryan F. Donnelly, Kenneth S. Hettie, Linda Chang, Howard E. Gendelman & Bhavesh D. Kevadiya. (2021) Nanocarrier vaccines for SARS-CoV-2. Advanced Drug Delivery Reviews 171, pages 215-239.
Crossref
Crossref
Pobitra Borah, Pran Kishore Deb, Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Katharigatta N. Venugopala, Vinayak Singh, Pottathil Shinu, Snawar Hussain, Satyendra Deka, Balakumar Chandrasekaran & Da’san M. M. Jaradat. (2021) Perspectives on RNA Vaccine Candidates for COVID-19. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Deborah Pushparajah, Salma Jimenez, Shirley Wong, Hibah Alattas, Nafiseh Nafissi & Roderick A. Slavcev. (2021) Advances in gene-based vaccine platforms to address the COVID-19 pandemic. Advanced Drug Delivery Reviews 170, pages 113-141.
Crossref
Crossref
Amit Kumar Sahu, M. Sreepadmanabh, Mahendra Rai & Ajit Chande. (2021) SARS-CoV-2: phylogenetic origins, pathogenesis, modes of transmission, and the potential role of nanotechnology. VirusDisease 32:1, pages 1-12.
Crossref
Crossref
Anna K. Blakney, Shell Ip & Andrew J. Geall. (2021) An Update on Self-Amplifying mRNA Vaccine Development. Vaccines 9:2, pages 97.
Crossref
Crossref
Suresh Kumar Chalapareddy, Andaleeb Sajid, Mritunjay Saxena, Kriti Arora, Rajan Guha & Gunjan Arora. 2021. Translational Biotechnology. Translational Biotechnology
267
286
.
Vikas Kushwaha, Anuprabha & R. C. Sobti. 2021. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications. Delineating Health and Health System: Mechanistic Insights into Covid 19 Complications
273
287
.
Roger Hewson. 2021. Human Viruses: Diseases, Treatments and Vaccines. Human Viruses: Diseases, Treatments and Vaccines
605
628
.
István Tombácz, Drew Weissman & Norbert Pardi. 2021. DNA Vaccines. DNA Vaccines
13
31
.
Iman M. Alfagih, Basmah Aldosari, Bushra AlQuadeib, Alanood Almurshedi & Mariyam M. Alfagih. (2020) Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines. Pharmaceutics 13:1, pages 45.
Crossref
Crossref
Zahraa S. Al-Ahmady & Hanene Ali-Boucetta. (2020) Nanomedicine & Nanotoxicology Future Could Be Reshaped Post-COVID-19 Pandemic. Frontiers in Nanotechnology 2.
Crossref
Crossref
A. A. Ilyichev, L. A. Orlova, S. V. Sharabrin & L. I. Karpenko. (2020) mRNA technology as one of the promising platforms for the SARS-CoV-2 vaccine development. Vavilov Journal of Genetics and Breeding 24:7, pages 802-807.
Crossref
Crossref
Yinan Xiao, Hanyue Xu, Wen Guo, Yunuo Zhao, Yuling Luo, Ming Wang, Zhiyao He, Zhenyu Ding, Jiyan Liu, Lei Deng, Fushen Sha & Xuelei Ma. (2020) Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines. Molecular Biomedicine 1:1.
Crossref
Crossref
Eduardo Ruiz‐Hitzky, Margarita Darder, Bernd Wicklein, Cristina Ruiz‐Garcia, Raquel Martín‐Sampedro, Gustavo del Real & Pilar Aranda. (2020) Nanotechnology Responses to COVID‐19. Advanced Healthcare Materials 9:19.
Crossref
Crossref
Giuseppe Lofano, Corey P. Mallett, Sylvie Bertholet & Derek T. O’Hagan. (2020) Technological approaches to streamline vaccination schedules, progressing towards single-dose vaccines. npj Vaccines 5:1.
Crossref
Crossref
E. G. Bogomolova, P. M. Kopeykin & A. A. Tagaev. (2020) Genetic engineering approaches to the development of modern therapeutics. Medical academic journal 20:3, pages 49-60.
Crossref
Crossref
Shuqin Xu, Kunpeng Yang, Rose Li & Lu Zhang. (2020) mRNA Vaccine Era—Mechanisms, Drug Platform and Clinical Prospection. International Journal of Molecular Sciences 21:18, pages 6582.
Crossref
Crossref
Gustavo Lou, Giulia Anderluzzi, Signe Tandrup Schmidt, Stuart Woods, Simona Gallorini, Michela Brazzoli, Fabiola Giusti, Ilaria Ferlenghi, Russell N. Johnson, Craig W. Roberts, Derek T. O'Hagan, Barbara C. Baudner & Yvonne Perrie. (2020) Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: The impact of cationic lipid selection. Journal of Controlled Release 325, pages 370-379.
Crossref
Crossref
Matthew D. Shin, Sourabh Shukla, Young Hun Chung, Veronique Beiss, Soo Khim Chan, Oscar A. Ortega-Rivera, David M. Wirth, Angela Chen, Markus Sack, Jonathan K. Pokorski & Nicole F. Steinmetz. (2020) COVID-19 vaccine development and a potential nanomaterial path forward. Nature Nanotechnology 15:8, pages 646-655.
Crossref
Crossref
Helena F. Florindo, Ron Kleiner, Daniella Vaskovich-Koubi, Rita C. Acúrcio, Barbara Carreira, Eilam Yeini, Galia Tiram, Yulia Liubomirski & Ronit Satchi-Fainaro. (2020) Immune-mediated approaches against COVID-19. Nature Nanotechnology 15:8, pages 630-645.
Crossref
Crossref
Yang-zhuo Gu, Xing Zhao & Xiang-rong Song. (2020) Ex vivo pulsed dendritic cell vaccination against cancer. Acta Pharmacologica Sinica 41:7, pages 959-969.
Crossref
Crossref
Denny Kim, James S. Robertson, Jean-Louis Excler, Richard C. Condit, Patricia E. Fast, Marc Gurwith, George Pavlakis, Thomas P. Monath, Jonathan Smith, David Wood, Emily R. Smith, Robert T. Chen & Sonali Kochhar. (2020) The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines. Vaccine 38:34, pages 5556-5561.
Crossref
Crossref
Giulia Anderluzzi, Gustavo Lou, Simona Gallorini, Michela Brazzoli, Russell Johnson, Derek T. O’Hagan, Barbara C. Baudner & Yvonne Perrie. (2020) Investigating the Impact of Delivery System Design on the Efficacy of Self-Amplifying RNA Vaccines. Vaccines 8:2, pages 212.
Crossref
Crossref
Tian Lu, Lee J. Klein, Sha Ha & Richard R. Rustandi. (2020) High-Resolution capillary electrophoresis separation of large RNA under non-aqueous conditions. Journal of Chromatography A 1618, pages 460875.
Crossref
Crossref
Xinyu Zhuang, Yanxin Qi, Maopeng Wang, Ning Yu, Fulong Nan, He Zhang, Mingyao Tian, Chang Li, Huijun Lu & Ningyi Jin. (2020) mRNA Vaccines Encoding the HA Protein of Influenza A H1N1 Virus Delivered by Cationic Lipid Nanoparticles Induce Protective Immune Responses in Mice. Vaccines 8:1, pages 123.
Crossref
Crossref
Zohreh Jahanafrooz, Behzad Baradaran, Jafar Mosafer, Mahmoud Hashemzaei, Tayebeh Rezaei, Ahad Mokhtarzadeh & Michael R. Hamblin. (2020) Comparison of DNA and mRNA vaccines against cancer. Drug Discovery Today 25:3, pages 552-560.
Crossref
Crossref
Abishek Wadhwa, Anas Aljabbari, Abhijeet Lokras, Camilla Foged & Aneesh Thakur. (2020) Opportunities and Challenges in the Delivery of mRNA-Based Vaccines. Pharmaceutics 12:2, pages 102.
Crossref
Crossref
Yu Fang. (2020) An Overview of the Progress Made on the Coronavirus Vaccine. E3S Web of Conferences 185, pages 03042.
Crossref
Crossref
Tim Beissert, Mario Perkovic, Annette Vogel, Stephanie Erbar, Kerstin C. Walzer, Tina Hempel, Silke Brill, Erik Haefner, René Becker, Özlem Türeci & Ugur Sahin. (2020) A Trans-amplifying RNA Vaccine Strategy for Induction of Potent Protective Immunity. Molecular Therapy 28:1, pages 119-128.
Crossref
Crossref
Janina Gergen & Benjamin Petsch. 2022. mRNA Vaccines. mRNA Vaccines
1
30
.
Chunxi Zeng, Chengxiang Zhang, Patrick G. Walker & Yizhou Dong. 2022. mRNA Vaccines. mRNA Vaccines
71
110
.
Shreyans Chatterjee, Sumanta Dey, Ashesh Nandy & Subhash C. Basak. 2021. Biophysical and Computational Tools in Drug Discovery. Biophysical and Computational Tools in Drug Discovery
195
220
.
Leroy Versteeg, Mashal M. Almutairi, Peter J. Hotez & Jeroen Pollet. (2019) Enlisting the mRNA Vaccine Platform to Combat Parasitic Infections. Vaccines 7:4, pages 122.
Crossref
Crossref
Cristina Manara, Michela Brazzoli, Diego Piccioli, Marianna Taccone, Ugo D'Oro, Domenico Maione & Elisabetta Frigimelica. (2019) Co-administration of GM-CSF expressing RNA is a powerful tool to enhance potency of SAM-based vaccines. Vaccine 37:30, pages 4204-4213.
Crossref
Crossref
Rino Rappuoli, Steven BlackDavid E. Bloom. (2019) Vaccines and global health: In search of a sustainable model for vaccine development and delivery. Science Translational Medicine 11:497.
Crossref
Crossref
Liu. (2019) A Comparison of Plasmid DNA and mRNA as Vaccine Technologies. Vaccines 7:2, pages 37.
Crossref
Crossref
Piotr S. Kowalski, Arnab Rudra, Lei Miao & Daniel G. Anderson. (2019) Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery. Molecular Therapy 27:4, pages 710-728.
Crossref
Crossref
Giulietta Maruggi, Cuiling Zhang, Junwei Li, Jeffrey B. Ulmer & Dong Yu. (2019) mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases. Molecular Therapy 27:4, pages 757-772.
Crossref
Crossref
Marcelo M. Samsa, Lesley C. Dupuy, Clayton W. Beard, Carolyn M. Six, Connie S. Schmaljohn, Peter W. Mason, Andrew J. Geall, Jeffrey B. Ulmer & Dong Yu. (2019) Self-Amplifying RNA Vaccines for Venezuelan Equine Encephalitis Virus Induce Robust Protective Immunogenicity in Mice. Molecular Therapy 27:4, pages 850-865.
Crossref
Crossref
Cuiling Zhang, Giulietta Maruggi, Hu Shan & Junwei Li. (2019) Advances in mRNA Vaccines for Infectious Diseases. Frontiers in Immunology 10.
Crossref
Crossref
Rein Verbeke, Ine Lentacker, Karine Breckpot, Jonas Janssens, Serge Van Calenbergh, Stefaan C. De Smedt & Heleen Dewitte. (2019) Broadening the Message: A Nanovaccine Co-loaded with Messenger RNA and α-GalCer Induces Antitumor Immunity through Conventional and Natural Killer T Cells. ACS Nano.
Crossref
Crossref
Lu Tan & Xun Sun. (2018) Recent advances in mRNA vaccine delivery. Nano Research 11:10, pages 5338-5354.
Crossref
Crossref
J Magarian Blander & Gaetan Barbet. (2018) Exploiting vita-PAMPs in vaccines. Current Opinion in Pharmacology 41, pages 128-136.
Crossref
Crossref
Rino Rappuoli & Emmanuel Hanon. (2018) Sustainable vaccine development: a vaccine manufacturer's perspective. Current Opinion in Immunology 53, pages 111-118.
Crossref
Crossref
Sung J. Yoo, Taeyong Kwon & Young S. Lyoo. (2018) Challenges of influenza A viruses in humans and animals and current animal vaccines as an effective control measure. Clinical and Experimental Vaccine Research 7:1, pages 1.
Crossref
Crossref
Rein Verbeke, Ine Lentacker, Laura Wayteck, Karine Breckpot, Mieke Van Bockstal, Benedicte Descamps, Christian Vanhove, Stefaan C. De Smedt & Heleen Dewitte. (2017) Co-delivery of nucleoside-modified mRNA and TLR agonists for cancer immunotherapy: Restoring the immunogenicity of immunosilent mRNA. Journal of Controlled Release 266, pages 287-300.
Crossref
Crossref